Literature DB >> 31147304

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial.

Laura S M Kerkmeijer1, Ruben Yannick G Tijssen, Sjoerd H Hofma, Rene J van der Schaaf, Karin E Arkenbout, Robin P Kraak, Auke Weevers, Jan J Piek, Robbert J de Winter, Jan G P Tijssen, Jose P S Henriques, Joanna J Wykrzykowska.   

Abstract

Entities:  

Year:  2019        PMID： 31147304     DOI： 10.4244/EIJ-D-19-00325

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  2 in total

1.  Scaffold Resorption Process Is Not the Achilles' Heel of the Absorb BVS: But What Then?

Authors:  Laura S M Kerkmeijer; Joanna J Wykrzykowska
Journal:  JACC Basic Transl Sci       Date:  2020-06-22

2.  Three-year outcomes of bioresorbable vascular scaffolds versus second-generation drug-eluting stents: Meta-analysis of randomized trials.

Authors:  Junsong Ke; Hongyu Zhang; Jun Huang; Ping Lv; Yun Chen; Kai Xu; Wenxue Yang; Bangyan Tu
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.